Bicycle Therapeutics (BCYC) Preferred Stock Liabilities (2018 - 2019)

Bicycle Therapeutics (BCYC) has 2 years of Preferred Stock Liabilities data on file, last reported at $54.6 million in Q1 2019.

• Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $54.6 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $54.6 million (changed 0.0% YoY) and the FY2018 annual result came in at $54.6 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities was little changed at $54.6 million in Q1 2019, from $54.6 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $54.6 million in Q1 2018 to a low of $54.6 million in Q1 2018.